Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
8.52
+0.62 (7.85%)
At close: Oct 5, 2026, 4:00 PM EDT
8.52
0.00 (0.00%)
Pre-market: Oct 6, 2026, 4:00 AM EDT

MRVI Revenue

Maravai LifeSciences Holdings had revenue of $51.44M in the quarter ending June 30, 2026, with 8.53% growth. This brings the company's revenue in the last twelve months to $208.78M, down -5.03% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%.

Revenue (ttm)
$208.78M
Revenue Growth
-5.03%
P/S Ratio
10.60
Revenue / Employee
$503,072
Employees
415
Market Cap
2.21B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
ADMA Biologics512.28M
Aurinia Pharmaceuticals311.51M
Vericel306.30M
UroGen Pharma188.73M
ADARx Pharmaceuticals6.13M
Revenue Rankings